ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000187.1|Asukamycin_1 # 454 # 2049 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.738	BGC0000187.1|Asukamycin_1 	454	2049	+	Loose	1000	48.1358	almE	24.52	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGTTGTTCCGGACGGCTGGTGGAGCCGGCACCGGGGCTACGCGGCCCGCATCATGTCCGCGCTCGACGCCGGCCCCGACCGCACCGCCGTGCACTGGCGGGGGCGGCCCGTCCCGGCGGGGGAGTTCGCCCGCACGGTCACCGGCGCCGCCGGCACCCTCAGGGAGCTGGGCGTGGGACCCGGCCGCGTGGTCGCCGTCCTGGTCGCGCCCAACAGCCCGGACATGCTCGCCGTGCGCTACGCGGTCCATCTGCTCGGCGGCGCGGTCTGCTACCTGCGCTCCACCAACCCCGGAGACACCTCCCACGTACTGTCCGCCGAGGCCCAGCTGCGCATCCTGCTGGACACCTCCGCCACCGTGCTGTTCACGGACCGGGAGCACGCGGCGCGCGCCCTGCTGCTCGCCGACCGGGCCCGCGGCCGGATCGCCGTCACCGGTTCCGGTGTGCGCGGGACAGGCGCCGTCCCGCCGGCCACCGGCGCGCGGGACGTGGCGGCCGCGGTCTGGGAGCCGGAGGCGCTGGCGCTGATCGCGTTCACCAGCGGCAGCACCGGGCGCCCCAAGGGCATCAGCCTGCCGGCCAGGGCCTGGGACAGCGTGGTGTCGGCCACCGGCGCGTCGATCGGCGAGGGCGACCGGGCCAGGCTGCTGGTCACCACCCCGCTCAGCCACACCGTCGGGCCGATGGCCGACGCGGTGCTCGCCGCGGGCGGTGCCGTCCACCTGCACGAGGACCTGGACGCGGACGCGGTGCTGCGGACCGTCGCCGAGCACCGGATCACCCGGACCTTCCTGGCCACCACCCACCTCTACCGACTCCTCGACCACGCCCGGACCGAGGACCACGACCTCACCTCGCTGCGTCAGCTGATCTACAGCGGCAGCGCCGCCGCCCCGGCCCGGATCGCGGAGGCGAACAAGGTGTTCGGCCCCGTTCTGGTGCAGGGCTACGGCACCAGCGAGGGCGGCCGGATCACCCTGCTCGATCCCGGCGACCACCAGGACCCGAGCCTGCTGAACACGGTGGGCCGTCCGTTCCCCGAGGTGGAGGTCACGATCCGCGACCCGGACACCGAACGGGAACTGACCACCGGGACGGTGGGCGAGGTCTGGGTGCGCTCGCCGCACGTGATGGCCGGCTACTGGTCGGACCCCGCGCTCAGCGCCCGTGTACTGCGCGACGGCTGGTACCGCACCGGCGACATCGGCCGCTTCGACGAGCGCGGATACCTGCATCTGCTGGACCGGGCCGCGGACGTCGTCAAGACCGACGGCGTCAAGGTCTACCCGGCCGTCGTCGAACGCGAGCTGCTGGCGGTGCCCGGAGTGGCGCAGGCCGCCGTGTACGGCGTCCGTGACCTGGACAACGTCGAGCATCTGCACGCCGCGATCGTGCCCCGGCCGGGTGCGCGGGTCGCCGTCGAGGACGTCCGCTCGCGCATCGGCACGGCCCTGTCCCCCCTGCACGTGCCCGAGGAGGTCCTGCTGCTGGACGAAATGCCGCTGAACGCCTCGGGCAAGCCCGACAAACCGCGGCTGCGGTTGCGTGAATCCGTACCGGCTCCCTACACGGAGAGTGAGTTGACCCGATGA	MVVPDGWWSRHRGYAARIMSALDAGPDRTAVHWRGRPVPAGEFARTVTGAAGTLRELGVGPGRVVAVLVAPNSPDMLAVRYAVHLLGGAVCYLRSTNPGDTSHVLSAEAQLRILLDTSATVLFTDREHAARALLLADRARGRIAVTGSGVRGTGAVPPATGARDVAAAVWEPEALALIAFTSGSTGRPKGISLPARAWDSVVSATGASIGEGDRARLLVTTPLSHTVGPMADAVLAAGGAVHLHEDLDADAVLRTVAEHRITRTFLATTHLYRLLDHARTEDHDLTSLRQLIYSGSAAAPARIAEANKVFGPVLVQGYGTSEGGRITLLDPGDHQDPSLLNTVGRPFPEVEVTIRDPDTERELTTGTVGEVWVRSPHVMAGYWSDPALSARVLRDGWYRTGDIGRFDERGYLHLLDRAADVVKTDGVKVYPAVVERELLAVPGVAQAAVYGVRDLDNVEHLHAAIVPRPGARVAVEDVRSRIGTALSPLHVPEEVLLLDEMPLNASGKPDKPRLRLRESVPAPYTESELTR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	95.50	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1632	colistin A; colistin B
BGC0000187.1|Asukamycin_2 # 2046 # 3275 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.715	BGC0000187.1|Asukamycin_2 	2046	3275	+	Loose	2000	29.6462	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	34.29	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGAACAAGCACCTGGACTTCTTCGCGCGCGAGATGGAGGAATTCGGCGCCCGGCGCCGGGAGTTCCTGGAGATCGGCCGACGCGCCGGCCGGTTCCCGAGTGCCGTGGCGCGGCAGGGGCAGGACGGCACCGACGTGGAGATCAGCGTCTGGTGCAGCAACGACTACCTGGGCATGGGCCAGAACCCGTTCGTGCTGGAAGCCGTGAAGAACGCCGTCGACGCCTTCGGCGCCGGATCCGGCGGCTCCCGCAACATCGGTGGCACCAACCACTACCACGTCCTGCTGGAGAACGAGCTGGCGGCGCTGCACGGCAAGGAGGAGGCGCTGATCTTCCCCTCCGGCTTCACGGCCAACGACGGCGCGCTGACCGTGCTGGCGGGCCGGGCGCCCGGCACCCTCGTCTTCTCCGACGAGCTGAACCATGCCTCGATCATCGACGGGCTGCGCCACTCCGGGGCCGAGAAGCGGATCTTCCGCCACAACGACATGGCGCACCTGGAGGAACTGCTGGCCGCCGCGGACCCGGAGCGGCCCAAGCTGATCGTGCTGGAGTCGGTGTACTCGATGTCCGGCGACATCGCGCCGCTCGCCGAGACCGCCGCCCTGGCCCGCCGTCACGGGGCGACCACCTTCATCGACGAGGTGCACGCGGTCGGCATGTACGGCCCGCAGGGTGCGGGCATCGCCGCCCGCGAAGGCATCGCCGACGAGTTCACCGTGGTCATGGGCACCCTGGCCAAGGGCTTCGGTACCGCCGGCGGCTACATCGCCGGTCCCGCCGCGCTGATCGACGCCGTCCGCAACTTCTCCCGCGGCTTCATCTTCACCACCTCCATCCCGCCGGCCACCGCCGCGGGCGCCCTCGCGGCCGTCCAGCACCTGCGCGCCTCCGAGGGGGAGCGCACCCGGCTCGCGGCCAACGCCGGTCTGCTGCACCGGCTGCTCAAGGAGCGGGACATCCCGTTCGTCTCGGACCAGTCGCACATCGTGTCCGTCTTCGTCGGCGACGACGGCCTGTGCCGGCAGGCGTCCGCCCTGCTGCTGGAGCGGCACGGGATCTACGTCCAGCCGATCAACGCGCCGAGCGTGCGGGCCGGCGAGGAGATCCTCCGGGTCGCCCCGTCCGCCACCCACACCACGGGCGACGTGGAGAAGTTCGCCGAGGCGGTCGAGGGCATCTGGCGGGACCTCGGCATCCCGCGCGCGCAGGAGCGGGCCGGGCGCTGA	MNKHLDFFAREMEEFGARRREFLEIGRRAGRFPSAVARQGQDGTDVEISVWCSNDYLGMGQNPFVLEAVKNAVDAFGAGSGGSRNIGGTNHYHVLLENELAALHGKEEALIFPSGFTANDGALTVLAGRAPGTLVFSDELNHASIIDGLRHSGAEKRIFRHNDMAHLEELLAAADPERPKLIVLESVYSMSGDIAPLAETAALARRHGATTFIDEVHAVGMYGPQGAGIAAREGIADEFTVVMGTLAKGFGTAGGYIAGPAALIDAVRNFSRGFIFTTSIPPATAAGALAAVQHLRASEGERTRLAANAGLLHRLLKERDIPFVSDQSHIVSVFVGDDGLCRQASALLLERHGIYVQPINAPSVRAGEEILRVAPSATHTTGDVEKFAEAVEGIWRDLGIPRAQERAGR	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	34.49	gnl|BL_ORD_ID|4719|hsp_num:0	2914			2622	2727	rifampin
BGC0000187.1|Asukamycin_3 # 3383 # 4918 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.711	BGC0000187.1|Asukamycin_3 	3383	4918	+	Loose	1000	79.337	almE	24.87	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGTCTCTCTCGGTGGCAGCGGTCCTCGCCGAGTCCGCGGCACGGCGACCGGACCATCCGGCGCTGATCCTCGGTGATCACGAGCTGACGTATGCTCAACTCTGGTATCAGGCACGGCAGTACGCGACCGTGCTGGCCGGCCGGGGGGTGGGTCCGGGCGACCGGGTGGCGCTGCTGCTGCCCAACACGGAGCACTTCCCCATGGCGTACTACGGAGCCCTGGCGATCGGGGCGGTCGTGGTGCCGGTGCATACCCTGCTCAAGGCCGACGAGATCGCGTACGTCCTGGGCGACTGCGGCGCCGATGTGCTGGTCTGCGCCGGGCCGTTGCTGGAAGAAGGCCGCAAGGGCGCCGATATGGCCGGAGTGCCGGTCCTCACCGTCCTCGACGAGGAGGGTGCGCGGGAGTCCCGGCTGGACGCGCTCGCGGAACCGGCCGCCCCGCTCGCCCGCTGCCTGCCGCGCCGGCCCGACGACCTGGCGGTGGTGCTCTACACCTCGGGCACCACCGGACGTCCCAAGGGCGCCATGCTCACCCATCTCAACGTCACGATGAACATCGGCGTGACGATGCTCTCCCCGTTCGACTTCACGGCCGACGACGTTCTGCTCGCCGTCCTGCCGCTGTTCCACACCTTCGGCCAGATCTGCGGCATGGGTGTCTGCTTCCGCGCCGGCGCGACGATGGTGCTGACGTCCGGTTTCGACGCGGCACGGACGCTGGACCTGATGGTGCGCCGCCGCTGCACGGTGTTCATGGGCGTCCCGACGATGTACATGGCCCTGCTCGACGCCGCCGCGCGCGACCCGCGCCGGCCCGCCCTGGACCGGGCGTTCTCGGGCGGATCGGCGCTTCCCGTGACGGTCCTGGAGGAGTTCCAGCGGACCTTCGGCTGCACCGTGTACGAAGGCTACGGACTCACCGAGACCTCACCCGTGGTCGCCTACAACCAGCGCGCCTGGCCCCCGCGCCCCGGAACCGTCGGCAAACCGGTCTGGGGCGTCGACGTGGAGATCGCCAGGGCCGATGTCGAGGGCCGGATCGAGGTGCTGCCGGCCGGGGAGGTCGGAGAGATCGTGATCCGGGGGCACAACGTGATGGCCGGCTACCTCGACCGGCCCGGGGCCACCGCCGAAGTGCTGGTGGACGGCTGGTTCCGCTCCGGCGACCTCGGAGTCAAGGACGAGGACGGCTACCTCAGCGTCGTGGACCGCAAGAAGGACATGGTGCTGCGCAACGGGTACAACGTGTACCCCCGGGAGATCGAGGAGGTACTGATGCGCCATCCCTCCGTCGCCCAGGTCGCCGTCGTGGGCGTGCCGGACCCGCGCCACGGCGAGGAGGTCTGCGCCGTGGTCGTCGCGGGCCCGGGATCGTCCCCCGGCGCCGGCCTCGGGGCGCGGCTCGTCGACTGGAGCAGGGAGCGGCTGGCGGCGTACAAGTACCCGCGCCGGGTGGAGTTCGTGGACGCGCTGCCGCTCGGCCCCAGCGGCAAGGTCCTCAAGCGGGAACTGGTGGCCCGGTACGGTGGCTGA	MSLSVAAVLAESAARRPDHPALILGDHELTYAQLWYQARQYATVLAGRGVGPGDRVALLLPNTEHFPMAYYGALAIGAVVVPVHTLLKADEIAYVLGDCGADVLVCAGPLLEEGRKGADMAGVPVLTVLDEEGARESRLDALAEPAAPLARCLPRRPDDLAVVLYTSGTTGRPKGAMLTHLNVTMNIGVTMLSPFDFTADDVLLAVLPLFHTFGQICGMGVCFRAGATMVLTSGFDAARTLDLMVRRRCTVFMGVPTMYMALLDAAARDPRRPALDRAFSGGSALPVTVLEEFQRTFGCTVYEGYGLTETSPVVAYNQRAWPPRPGTVGKPVWGVDVEIARADVEGRIEVLPAGEVGEIVIRGHNVMAGYLDRPGATAEVLVDGWFRSGDLGVKDEDGYLSVVDRKKDMVLRNGYNVYPREIEEVLMRHPSVAQVAVVGVPDPRHGEEVCAVVVAGPGSSPGAGLGARLVDWSRERLAAYKYPRRVEFVDALPLGPSGKVLKRELVARYGG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	91.91	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1650	colistin A; colistin B
BGC0000187.1|Asukamycin_4 # 5001 # 6116 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.725	BGC0000187.1|Asukamycin_4 	5001	6116	-	Loose	350	26.9498	vanM	29.27	3002911	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	GTGGAAAGAATCAGCTTCGGCGCCTTCCTCTCACCACTCCACCCGCTGGGCGAGGACCCGGGCCTGAGCCTCTGGCGCGACCTCGAACTCGCCGAATGGCTAGACCAGTTCGGCTACGAGGAGCTCTGGGTCGGCGAACACCACTCGGCCGGCTGGGGGACCATCTCCTCGCCCGAGCTGTTCATCGCCACCGCGGCCGAGCGGACCCGGCGCATCCGGCTCGGCACCGGAGTCGTCAGCCTGCCCTACCACCACCCGTTCATGGTGGCCTCGCGGGCCGTGCAGCTCGACCATCTGACCGGCGGGCGCTTCACCCTCGGGGTCGGCGCGGGCTCGATCCCGTCCGACATGCACTTCCTGGGCATCGACCCCGCGGACACCCGCCGTCGCACCGCCGAGTCATTGGACGTGATCCACCGCCTGCTCACCGGCGACGAACCGGTCACCCGGGTCACCGACTGGTTCGAACTGCACGACGCCCGGCTGCAGTTGCGTCCGCGCCGGGCCTCCGGCCTGCCGCTGGCGGTCTCCAGCGCCGTCTCCCCGTTCGGCATGCGGCTGGCCGGACAGTACGGTGCCGCCCCGCTCTCCTTCGGCGTCCCGCCCCGGCCGGGCTCCTCCGTCGACGACCTGGCCGCCCAGTGGCAGCACGCCGTGGATTCGGCGGCCGAGCACGGACGCACCATCGACCGGGCCGACTGGCGGGTCGCCCTGTCGGTGCATGTCGCGGACAGCCGCGAGCAGGCGCTCGACGACCTCGTCGACGGCTGGATGCGCTACCGCAACGAGTACTGGGCGCTGCTCGGCACCCCGCCGGTGCACTCGCGGACGGAGGCCCGCAAGGCCCTGGCCGAGCTGATCGACCGGCGCAGCACGATCGTCGGCTCGGTCGACGAGTGCATCGACGCGGTACGCGACGTGCAGGAGGCGACCGGCGGATTCGGCCGGCTGCTGGTGAACGTCCTGGACTGGGCGGACCGGGAGGCGATGAAGCGCAGCTTCGAGCTGTTCGCCCGCTTCGTGGCGCCCCGGTTCAACGGCTCGCTGGACGGCGTCACGGCGTCGTACGGGTGGGTCGCCGAGCAGGCCCGGGCCCAGCGCGCCGCCGCCCGGTAG	MERISFGAFLSPLHPLGEDPGLSLWRDLELAEWLDQFGYEELWVGEHHSAGWGTISSPELFIATAAERTRRIRLGTGVVSLPYHHPFMVASRAVQLDHLTGGRFTLGVGAGSIPSDMHFLGIDPADTRRRTAESLDVIHRLLTGDEPVTRVTDWFELHDARLQLRPRRASGLPLAVSSAVSPFGMRLAGQYGAAPLSFGVPPRPGSSVDDLAAQWQHAVDSAAEHGRTIDRADWRVALSVHVADSREQALDDLVDGWMRYRNEYWALLGTPPVHSRTEARKALAELIDRRSTIVGSVDECIDAVRDVQEATGGFGRLLVNVLDWADREAMKRSFELFARFVAPRFNGSLDGVTASYGWVAEQARAQRAAAR	MNRLKIAILFGGCSEEHNVSVKSAAEIANNIDIGKYEPIYIGITQSGVWKTCEKPCIDWDNEHCRSAVLSPDKKMHGLLIMQDKGYQIQRIDVVFSVLHGKSGEDGAIQGLFELSGIPYVGCDIQSSAVCMDKSLAYIIAKNAGIATPEFQVIYKDDKPAADSFTYPVFVKPARSGSSYGVNKVNSADELDSAIDLARQYDSKILIEQGVLGYEVGCAVLGNSFDLIVGEVDQIRLQHGIFRIHQEAEPEKGSENATITVPAELSAEERERIKEAAKNIYKALGCRGLSRVDMFLQDNGRIVLNEVNTMPGFTSYSRYPRMMVSAGITIPELIDHLIVLAVKE	108.16	gnl|BL_ORD_ID|1774|hsp_num:0	1924			42	165	vancomycin; teicoplanin
BGC0000187.1|Asukamycin_8 # 8384 # 8659 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.681	BGC0000187.1|Asukamycin_8 	8384	8659	-	Loose	450	23.8682	Erm(O)-lrm	59.09	3004652	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTATGAAGAGACCCGCGAGTTCATCCTGACCGTGATCAGGGACGTGATCAACCTCCCGCTGCCCGCCGAGGTCGAGGACGACCTGCCGCTCGGCGAAGAGGGCCTGGGACTGGAATCGCTCGCCACGATCGAGCTGGTGCTCCAGCTGGAGGGCCAGTACGGCATCGAGCTGCCCGAGGAAGAACTCGACCCCGCCCTCGTCCCGGACCTCCGCGCCTTCGTGCGGACCGTGGTCGAGCGGCGCGCGGCGACAGCGGAGAGCGTAGCCCGGTGA	MYEETREFILTVIRDVINLPLPAEVEDDLPLGEEGLGLESLATIELVLQLEGQYGIELPEEELDPALVPDLRAFVRTVVERRAATAESVAR	MARPTQRARTLSQNFLADRATAERVARLAVPDRGRPPLLLEVGAGNGALTEPLARRSRELHAYEIDPRLVPGLRARFARSPHVHVVAGDFLTARPPRTPFAVAGNVPFSRTADIVDWCLTAPGLTDATLLTQLEYARKRTGDYGRWTLLTVLTWPRHEWRLVGRVGRSRFCPAPRVDAGILRIERRPTALLTGAAARRDWADLVELGFSGVGGSLHASLRRAHSRRRVDAAFRAARLDPGVLVGEVAPDRWLRLHEELTA	35.00	gnl|BL_ORD_ID|2181|hsp_num:0	3351			174	240	erythromycin; lincomycin; tylosin
BGC0000187.1|Asukamycin_9 # 8740 # 9576 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.734	BGC0000187.1|Asukamycin_9 	8740	9576	-	Loose	1900	25.7942	MuxB	42.86	3004074	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGACCAAGTTCCGGAGGGACGGCGGTCCGCCTGGCGCGGCTGTCCCGGCACTGCGACGAACGATTCCTCTTCGTCCCGATGGATCACTCGGTGGCGGACGGTCCCATCGTCCCCGCCGCGCGGTTCAACGGACTCGTCCGCACGGCCGTGGAGGGCGGCGCCGACGCCGTCGTGGTGCACAAGGGGCGGGCGGCGAGCATCGAGGCGGGACTGCTGCGGAACTGCTCCCTGGTCGTGCACCTGAGCGCCAGCACGGCGCACGCCCGCGACGCGGACGCCAAGGTGCTGGTCGGCGATGTCGAGGAGGCCGTCCGGCTGGGCGCCGACGCGGTGAGCGTGCAGGTGAACATCGGCTCCGAGACCGAGAGCCGCCAGCTGGCCGACCTCGGTTCGGTGGCCGATGCCTGCCGGCGCTGGAACGTACCGCTGCTGGCCATGGTGTATCCCCGCGGGCCGCGGATCGCCGATCCGCACGATCCGGCGCTGCTCTCCCATGTCGTCAACGTGGCCGCCGACCTCGGCGCCGACCTGGTGAAGACGACCTGGGCGACGCCGCTGGAGCGGCTGGCGGACGTCGTGGAGAGCTGCCCGATACCGGTACTGGCGGCAGGCGGTCCGAGCAGTCCCGGTGTCGATCCGGTCGCATACGCCTCCGGGGTGATGGCGGCCGGCTGCGCCGGTCTGGCCATCGGCCGCACCTTCTTCGAGAGCAGCTCGCCCGCCCGCGTGATCCGCGCGCTCTCGGCCGTGGTCCACCGGGCCCCGGCCGACGCCGGGCACGACTCCCTGCCCGCGGACCCGCTCGACCCGGCCCGGCCCGTACCGGTCCGTTGA	MRPSSGGTAVRLARLSRHCDERFLFVPMDHSVADGPIVPAARFNGLVRTAVEGGADAVVVHKGRAASIEAGLLRNCSLVVHLSASTAHARDADAKVLVGDVEEAVRLGADAVSVQVNIGSETESRQLADLGSVADACRRWNVPLLAMVYPRGPRIADPHDPALLSHVVNVAADLGADLVKTTWATPLERLADVVESCPIPVLAAGGPSSPGVDPVAYASGVMAAGCAGLAIGRTFFESSSPARVIRALSAVVHRAPADAGHDSLPADPLDPARPVPVR	MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMTSSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLPNDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGGQRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADAYRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRIKALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATLIPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSPLEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLTLTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLALTALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYIGVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDRVARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASRLGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQVRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQGSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLALMLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPILMTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRWAAWRKQRGLDLNTEAGFDGDAGR	26.65	gnl|BL_ORD_ID|2364|hsp_num:0	2718			2319	2400	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000187.1|Asukamycin_11 # 10688 # 11116 # 1 # ID=1_11;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.660	BGC0000187.1|Asukamycin_11 	10688	11116	+	Loose	900	67.781	emrB	37.5	3000074	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCGCTCCAGGGCAAGGTCCACGAGGGAAGGCCAGTTGTGAAAGCGAAAAAGGCTCCGGTCGAGGCCGGTGGGTCCGACCGTGTGACTCCAGAACTCTGGTGGCTGAGCGGCATCATGGCCTTAGGCGGCTTCGCCAGCCTGCTGGACGCGACCATCATCAACGTCGCCATCGGGCCGCTCGCCAAAGTGTTCGACTCCGACCTCGCCACCGTTCAATGGGTGGTGACCGGGTACCTGCTCGCCATCACCGCGGCGATCCCGATGAGTGGCTGGGCCACGGCCCGGTTCGGCGCGAAACAGACGGTCATCTTCTCGCAGGTCGTCTTCCTGGTCGGCTCATTGCTCTCCGGCCTGGCCTGGTCCGCGTCCAGCCTGATCATCTTCCGGGTGATCCAGGGCATCGGCGGCGGCCTGGCGGTCCCGGTG	MALQGKVHEGRPVVKAKKAPVEAGGSDRVTPELWWLSGIMALGGFASLLDATIINVAIGPLAKVFDSDLATVQWVVTGYLLAITAAIPMSGWATARFGAKQTVIFSQVVFLVGSLLSGLAWSASSLIIFRVIQGIGGGLAVPV	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLVLLGLVWFAKPPFGAGGGGGGAH	27.93	gnl|BL_ORD_ID|1706|hsp_num:0	1847			54	366	nalidixic acid
BGC0000187.1|Asukamycin_6 # 6941 # 8134 # -1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.744	BGC0000187.1|Asukamycin_6 	6941	8134	-	Loose	750	169.088	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	39.25	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGCCTCGTGAGGTGGCGATCACCGGCTACGGAGTCCTGACGGCCTTCGGATTCGGCGCCGACGCCCTGCGCCGCGGCGTCTTCGGGGGCAGGCCCGGCTTCGTCCCCGTCAGCCGCTTCGACCCGACCCCCTTCCACGCCGGCCGGGCCGCCACCTTCGAGGGCGCCGGGCCGGAGATTCCCGGGGTCGTGGTCAAGCCCGGCTACACACCGACCCAGGCCGAGGTGCTGCACGCCTGCACCGCCGAAGCGCTCCGGGTCGCGGGCACCGACGCCCGCGACGCCCCCGTCCTGCTGGGCACCAACGGCGACCACTCGGCGGCCCGGACGTTCTGGACGGACCAGGCCGAGGGGCGCGACAGCACCGACCCGCGCATCCTGGACAGCCTGCCGGCGGCACTGCCCCGGCGGATCGGCGAGGCATTCGGCCTGGGCTCTCCGCGCCTGGCCTTCGTCAACGCCTGCGTCGCCTCGACCAACAGCATCACGTACGGCGCCGAGCTGATCCGGCGGGGGTCGGCCGACACCGTGGTCTGCGGCGGCGCGTATCTGGTCACCGAGGACGTCTTCGCCAAGTTCGACTCCGGCCGGGCGCTCAGCAAGGAGGGCGTGGTGCGCCCGTTCGCCGCGGGCCGGGCCGGGCTGCTCCAGGGCGACGGCGCCGCGGTCCTGGTGCTGGAGTCCGCAGAACGCGCACGGGCCCGCGGCACCGAGGTGCTGGCCGAGCTGGTCGGCTGGGGCATGGCGGCCGACGCGTACCACGTGGTCAAACCGCACCCGCGGGGCGAGGGCCTGGCACGGGCCGCGAGCGCCGCGCTCCGCAGGGCGGGGCTGGCACCGAAGGACATCGGATACGTCAACGCGCACGGGACGGGCACCCCTTTGAACGACGTGGCGGAGACGGCCGCGCTGCACGGCGTCTTCGGCGAACACGCGCACCGCGTGCCGGTCAGCTCGACCAAGAGCAGCACCGGTCACATGCTGGAGGCCACCGGCGCCGTGGAGGCGGTGATCACTCTCCTCGCGCTGCGCGACGGCCTGCTGCCGCCCACGATCGGCTACCAGGAGCCGGACCCCGCCTGCGACCTGGACTACGTCCCGAACCGGGCCCGGCCCGCAGAGATCACCCACGCGCTCTCGCTCAACGCCGCCTTCGGCGGGGTCAACGCCGCACTCGTGCTGAAGCGGGTGTGA	MPREVAITGYGVLTAFGFGADALRRGVFGGRPGFVPVSRFDPTPFHAGRAATFEGAGPEIPGVVVKPGYTPTQAEVLHACTAEALRVAGTDARDAPVLLGTNGDHSAARTFWTDQAEGRDSTDPRILDSLPAALPRRIGEAFGLGSPRLAFVNACVASTNSITYGAELIRRGSADTVVCGGAYLVTEDVFAKFDSGRALSKEGVVRPFAAGRAGLLQGDGAAVLVLESAERARARGTEVLAELVGWGMAADAYHVVKPHPRGEGLARAASAALRRAGLAPKDIGYVNAHGTGTPLNDVAETAALHGVFGEHAHRVPVSSTKSSTGHMLEATGAVEAVITLLALRDGLLPPTIGYQEPDPACDLDYVPNRARPAEITHALSLNAAFGGVNAALVLKRV	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	95.43	gnl|BL_ORD_ID|1968|hsp_num:0	1943			459	1245	isoniazid
